FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034777746> ?p ?o ?g. }

• W2034777746 endingPage "1393" @default.
• W2034777746 startingPage "1393" @default.
• W2034777746 abstract "Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer Mayu Ono, Tokiko Ito, Toshiharu Kanai, Koichi Murayama, Hiroshi Koyama, Kazuma Maeno, Yasuhiro Mochizuki, Asumi Iesato, Toru Hanamura, Toshihiro Okada, Takayuki Watanabe, Ken-ichi ItoDivision of Breast and Endocrine Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto, JapanAbstract: Bevacizumab when combined with chemotherapy exerts significant activity against many solid tumors through tumor angiogenesis inhibition; however, it can induce severe side effects. We report the rare case of a 27-year-old premenopausal woman with locally advanced breast cancer that was marked by rapid tumor necrosis followed by massive hemorrhage shortly after bevacizumab and paclitaxel administration. On the basis of histopathological examination of a biopsy specimen and computed tomography findings, she was diagnosed with stage IV estrogen and progesterone receptor-negative and human epidermal growth factor receptor type 2-positive breast cancer with multiple organ metastases when she had entered gestational week 24. Cyclophosphamide, Adriamycin®, fluorouracil therapy was initiated, but multiple liver metastases continued to progress. A healthy fetus was delivered by induced delivery and trastuzumab-based treatment was initiated. Although the multiple liver metastases were controlled successfully by trastuzumab combined with paclitaxel, the primary tumor continued to expand even after subsequent administration of three other treatment regimens including anti-human epidermal growth factor receptor type 2 agents and cytotoxic drugs. To inhibit primary tumor growth, a combination therapy with paclitaxel and bevacizumab was subsequently initiated. Following therapy initiation, however, the large tumor occupying the patient&#39;s entire left breast became necrotic and ulcerated rapidly. Furthermore, massive hemorrhage from the tumor occurred 5 weeks after bevacizumab-based therapy initiation. Although hemostasis was achieved by manual compression, the patient required blood transfusion for the massive blood loss. She eventually succumbed to respiratory failure. This case report demonstrates that primary breast cancer lesions with skin involvement have the potential to cause massive hemorrhage after bevacizumab-based treatment.Keywords: bevacizumab, breast cancer, necrosis, hemorrhage, adverse event, paclitaxel" @default.
• W2034777746 created "2016-06-24" @default.
• W2034777746 creator A5010006689 @default.
• W2034777746 creator A5048998219 @default.
• W2034777746 creator A5049076885 @default.
• W2034777746 creator A5049344769 @default.
• W2034777746 creator A5051897132 @default.
• W2034777746 creator A5058047435 @default.
• W2034777746 creator A5058848395 @default.
• W2034777746 creator A5063645356 @default.
• W2034777746 creator A5065349572 @default.
• W2034777746 creator A5066670138 @default.
• W2034777746 creator A5068520133 @default.
• W2034777746 creator A5078645044 @default.
• W2034777746 date "2013-10-01" @default.
• W2034777746 modified "2023-10-18" @default.
• W2034777746 title "Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer" @default.
• W2034777746 cites W2004791242 @default.
• W2034777746 cites W2012852444 @default.
• W2034777746 cites W2018831974 @default.
• W2034777746 cites W2019930901 @default.
• W2034777746 cites W2046507292 @default.
• W2034777746 cites W2050380363 @default.
• W2034777746 cites W2064795528 @default.
• W2034777746 cites W2098737602 @default.
• W2034777746 cites W2100785570 @default.
• W2034777746 cites W2118588996 @default.
• W2034777746 cites W2121785313 @default.
• W2034777746 cites W2122525783 @default.
• W2034777746 cites W2143064330 @default.
• W2034777746 cites W2148722667 @default.
• W2034777746 cites W2157769714 @default.
• W2034777746 cites W2168236082 @default.
• W2034777746 doi "https://doi.org/10.2147/ott.s51164" @default.
• W2034777746 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3794845" @default.
• W2034777746 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24124381" @default.
• W2034777746 hasPublicationYear "2013" @default.
• W2034777746 type Work @default.
• W2034777746 sameAs 2034777746 @default.
• W2034777746 citedByCount "3" @default.
• W2034777746 countsByYear W20347777462021 @default.
• W2034777746 countsByYear W20347777462022 @default.
• W2034777746 countsByYear W20347777462023 @default.
• W2034777746 crossrefType "journal-article" @default.
• W2034777746 hasAuthorship W2034777746A5010006689 @default.
• W2034777746 hasAuthorship W2034777746A5048998219 @default.
• W2034777746 hasAuthorship W2034777746A5049076885 @default.
• W2034777746 hasAuthorship W2034777746A5049344769 @default.
• W2034777746 hasAuthorship W2034777746A5051897132 @default.
• W2034777746 hasAuthorship W2034777746A5058047435 @default.
• W2034777746 hasAuthorship W2034777746A5058848395 @default.
• W2034777746 hasAuthorship W2034777746A5063645356 @default.
• W2034777746 hasAuthorship W2034777746A5065349572 @default.
• W2034777746 hasAuthorship W2034777746A5066670138 @default.
• W2034777746 hasAuthorship W2034777746A5068520133 @default.
• W2034777746 hasAuthorship W2034777746A5078645044 @default.
• W2034777746 hasBestOaLocation W20347777461 @default.
• W2034777746 hasConcept C121608353 @default.
• W2034777746 hasConcept C126322002 @default.
• W2034777746 hasConcept C142724271 @default.
• W2034777746 hasConcept C143998085 @default.
• W2034777746 hasConcept C2775930923 @default.
• W2034777746 hasConcept C2776694085 @default.
• W2034777746 hasConcept C2776755627 @default.
• W2034777746 hasConcept C2776999253 @default.
• W2034777746 hasConcept C2777292972 @default.
• W2034777746 hasConcept C2777802072 @default.
• W2034777746 hasConcept C2779786085 @default.
• W2034777746 hasConcept C2781190966 @default.
• W2034777746 hasConcept C530470458 @default.
• W2034777746 hasConcept C71924100 @default.
• W2034777746 hasConceptScore W2034777746C121608353 @default.
• W2034777746 hasConceptScore W2034777746C126322002 @default.
• W2034777746 hasConceptScore W2034777746C142724271 @default.
• W2034777746 hasConceptScore W2034777746C143998085 @default.
• W2034777746 hasConceptScore W2034777746C2775930923 @default.
• W2034777746 hasConceptScore W2034777746C2776694085 @default.
• W2034777746 hasConceptScore W2034777746C2776755627 @default.
• W2034777746 hasConceptScore W2034777746C2776999253 @default.
• W2034777746 hasConceptScore W2034777746C2777292972 @default.
• W2034777746 hasConceptScore W2034777746C2777802072 @default.
• W2034777746 hasConceptScore W2034777746C2779786085 @default.
• W2034777746 hasConceptScore W2034777746C2781190966 @default.
• W2034777746 hasConceptScore W2034777746C530470458 @default.
• W2034777746 hasConceptScore W2034777746C71924100 @default.
• W2034777746 hasLocation W20347777461 @default.
• W2034777746 hasLocation W20347777462 @default.
• W2034777746 hasLocation W20347777463 @default.
• W2034777746 hasLocation W20347777464 @default.
• W2034777746 hasOpenAccess W2034777746 @default.
• W2034777746 hasPrimaryLocation W20347777461 @default.
• W2034777746 hasRelatedWork W2001196910 @default.
• W2034777746 hasRelatedWork W2033292737 @default.
• W2034777746 hasRelatedWork W2075810095 @default.
• W2034777746 hasRelatedWork W2090416595 @default.
• W2034777746 hasRelatedWork W2137228442 @default.
• W2034777746 hasRelatedWork W2343994751 @default.
• W2034777746 hasRelatedWork W2752875184 @default.

• next